logo-loader
viewWattle Health Australia Ltd

Wattle Health Australia eyes Chinese infant formula market

Commencing initial supply of its infant formula to 100 key stores.

shutterstock_191085812_58f5a31828e11.jpg
The company listed on the ASX in March 2017

Recently listed Wattle Health Australia (ASX:WHA) has signed an agreement with one of the largest retailers of mother and baby products in China - Aiyingdao Zhuhai Business Chain.

As part of the agreement, Wattle Health will commence initial supply of its infant formula to 100 key stores of Aiyingdao across mainland China.

It is worth noting that Aiyingdao’s network is responsible for 40% of all infant formula sales in China, with over 1000 retail store locations.

The companies are also commencing negotiations to formalise a long-term supply agreement to market infant formula across the entire Aiyingdao network in mainland China.

Based in Melbourne Victoria, Wattle Health is in the business of developing and marketing consumer food products, with an initial focus on dairy products (dried milk and infant formula).

The company listed on the ASX in March 2017 after raising $8 million from an oversubscribed initial public offer.

Interestingly, the company’s shares were last trading at $0.40, double the issue price of $0.20.

Wattle Health uses only Australian manufacturers to manufacture its products.

This is intended to promote and leverage on the brand positively in Australia and in export markets, as there is growing consumer sentiment for Australian made food products.

Quick facts: Wattle Health Australia Ltd

Price: 0.53 AUD

ASX:WHA
Market: ASX
Market Cap: $103.09 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Piedmont Lithium secures landmark Section 404 Permit to...

Piedmont Lithium Ltd (ASX:PLL) CEO Keith Phillips tells Proactive the lithium explorer has received the Section 404 Permit under the Clean Water Act from the US Army Corps of Engineers for its lithium project in North Carolina. Phillips says this landmark achievement follows a fair, albeit...

1 day, 17 hours ago

2 min read